• 53 Hits
  • 検索条件 : 絞込み (MeSH = Deoxycytidine / pharmacology)
生物種 リソース名 タイトル
ヒト・動物細胞 PANC-1(RCB2095) , PK-59(RCB1901) Increased mitochondria are responsible for the acquisition of gemcitabine resistance in pancreatic cancer cell lines.
ヒト・動物細胞 SSP-25(RCB1293) Mucin 4 Confers Gemcitabine Resistance and an Unfavorable Prognosis in Patients with Cholangiocarcinoma via AKT Activation.
ヒト・動物細胞 TGBC2TKB(RCB1130) GLI2 but not GLI1/GLI3 plays a central role in the induction of malignant phenotype of gallbladder cancer.
ヒト・動物細胞 MOLT-4(RCB0206) 2-Chloro-2'-deoxyadenosine induces apoptosis through the Fas/Fas ligand pathway in human leukemia cell line MOLT-4.
ヒト・動物細胞 HuCCT1(RCB1960) Histone deacetylase inhibitor enhances the anti-tumor effect of gemcitabine: a special reference to gene-expression microarray analysis.
ヒト・動物細胞 TGBC1TKB(RCB1129) , TGBC2TKB(RCB1130) Guggulsterone enhances antitumor activity of gemcitabine in gallbladder cancer cells through suppression of NF-κB.
ヒト・動物細胞 MCF7(RCB1904) Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansine.
ヒト・動物細胞 HuCCT1(RCB1960) , HuH-28(RCB1943) , TFK-1(RCB2537) , TKKK(RCB1907) , TGBC2TKB(RCB1130) , TGBC14TKB(RCB1186) , TGBC18TKB(RCB1169) Establishment and biological characterization of a novel cell line derived from hepatoid adenocarcinoma originated at the ampulla of Vater.
ヒト・動物細胞 HuCCT1(RCB1960) , SSP-25(RCB1293) , RBE(RCB1292) , YSCCC(RCB1549) , TGBC24TKB(RCB1196) , TFK-1(RCB2537) Synergistic antiproliferative effects of an mTOR inhibitor (rad001) plus gemcitabine on cholangiocarcinoma by decreasing choline kinase activity.
遺伝子材料 PINK1_WT-IRES-GFP-NLS (RDB18946) , PINK1_KD-IRES-GFP-NLS (RDB18947) , MUL1_WT-IRES-GFP-NLS (RDB18948) , MUL1_LD-IRES-GFP-NLS (RDB18949) Gemcitabine induces Parkin-independent mitophagy through mitochondrial-resident E3 ligase MUL1-mediated stabilization of PINK1.
ヒト・動物細胞 HS-Sch-2(RCB2230) , YST-1(RCB2136) , HS-PSS(RCB2362) Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors.
ヒト・動物細胞 MIA Paca2(RCB2094) Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factors.
ヒト・動物細胞 TFK-1(RCB2537) , HuCCT1(RCB1960) Overexpression of karyopherin-α2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins.
ヒト・動物細胞 MBT-2(RCB0544) Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC.
ヒト・動物細胞 RERF-LC-AI(RCB0444) , RERF-LC-KJ(RCB1313) , LC-2/ad(RCB0440) , A549 Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells.
ヒト・動物細胞 KP4(RCB1005) Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer.
ヒト・動物細胞 BOY-12E(RCB2627) , JMSU1(RCB2227) ASP5878, a selective FGFR inhibitor, to treat FGFR3-dependent urothelial cancer with or without chemoresistance.
ヒト・動物細胞 HuCCT1(RCB1960) , HuH-28(RCB1943) Anoikis-resistant cholangiocarcinoma cells display aggressive characteristics and increase STAT3 activation.
ヒト・動物細胞 RBE(RCB1292) , HuCCT1(RCB1960) , SSP-25(RCB1293) , TGBC24TKB(RCB1196) , TFK-1(RCB2537) ATM Inhibitor Suppresses Gemcitabine-Resistant BTC Growth in a Polymerase θ Deficiency-Dependent Manner.
ヒト・動物細胞 A549(RCB0098) Rho-Associated Protein Kinase (ROCK) Inhibitors Inhibit Survivin Expression and Sensitize Pancreatic Cancer Stem Cells to Gemcitabine.